This is a posting from the Advanced Research Projects Agency for Health (ARPA H) soliciting proposals from small business concerns (SBCs) with research and development (R&D) expertise. The solicitation is for innovative research that will contribute to ARPA H's mission needs and the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) program objectives. The posting is for informational purposes only and is a draft, subject to change. It is not a formal request for solution summaries or technical presentations. The SBIR and STTR programs aim to stimulate technological innovation, strengthen the role of small businesses in federal R&D, encourage participation by disadvantaged and women-owned small businesses, and increase private sector commercialization of innovations. The posting defines a small business concern and lists several anticipated research topics, including development of an annual fertility test, versatile bioadhesives with antimicrobial properties, a universal platform for living adaptive toxin removal, a non-invasive therapy for endometriosis, technologies originating from ARPA H efforts, a rapid diagnostic test for multi-system autoimmune disease, and a virtual human brain for neurosurgical robotics development.
The bid notice states that the solicitation is anticipated to have a closing date of TBD for receipt of proposals.
The bid notice states that a small business concern is any business concern that, on the date of award, is organized for profit, with a place of business located in the United States, which operates primarily within the United States or which makes a significant contribution to the United States economy through payment of taxes or use of American products, materials or labor; is in the legal form of an individual proprietorship, partnership, limited liability company, corporation, joint venture, association, trust or cooperative, except that where the form is a joint venture, there must be less than 50 percent participation by foreign business entities in the joint venture; more than 50 directly owned and controlled by one or more individuals who are citizens or permanent resident aliens of the United States, other business concerns each of which is more than 50 directly owned and controlled by individuals who are citizens or permanent resident aliens of the United States, or any combination of these or more than 50 owned by multiple venture capital operating companies, hedge funds, private equity firms, or any combination of these. no single venture capital operating company, hedge fund, or private equity firm may own more than 50 of the concern and, has, including its affiliates, no more than 500employees.